Effectiveness and safety of plasma exchange for anti-MDA5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease refractory to intensive immune suppression therapy: A case series.

Tomoka WatanabeMisaki TaniguchiSanae OguraMea AsouShunsuke TakayanagiYuko SokaiYoshiki TsujiKeita P MoriTomomi EndoToshiki NakajimaYoshitaka ImuraTatsuo Tsukamoto

Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2024)

PEx might be a promising option for controlling the disease activity of anti-MDA5 Ab-positive CADM with severe RP-ILD and may contribute to better survival.

Keyphrases

interstitial lung disease
rheumatoid arthritis
disease activity
systemic sclerosis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
breast cancer cells
idiopathic pulmonary fibrosis
juvenile idiopathic arthritis
multiple sclerosis
stem cells
free survival
bone marrow